SOLENO THERAPEUTICS INC - COMM (SLNO)

Historical Portfolio Holders from Q4 2017 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COMM
Shares, excl. options Q2 2024
550K
Holdings value Q2 2024
$22.4M
Value change Q2 2024
$0
Grand Portfolio weight change Q2 2024
0%
Number of holders
1
Number of buys Q2 2024
0
Number of sells Q2 2024
0
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 550K $22.4M $0 $40.80 1
2024 Q1 550K $23.5M +$23.5M $42.80 1
2022 Q4 0 $0 -$171K 0
2022 Q3 102K $171K -$7.97M $1.71 2
2022 Q2 45.1M $8.11M -$1.16M $0.19 32
2022 Q1 47M $11.2M +$4.21M $0.22 33
2021 Q4 27.9M $11.5M -$308K $0.41 33
2021 Q3 28.5M $26.3M -$434K $0.92 34
2021 Q2 28.7M $32.6M -$3.74M $1.14 46
2021 Q1 31.8M $40.1M -$21.8M $1.26 61
2020 Q4 43.9M $84.6M -$1.4M $1.93 67
2020 Q3 43.3M $108M +$2.78M $2.51 63
2020 Q2 42.5M $94.3M +$48.3M $2.22 66
2020 Q1 20.6M $48M +$7.6M $2.38 29
2019 Q4 17.2M $50M +$20.7M $2.94 17
2019 Q3 10.1M $15M -$12.3M $1.50 16
2019 Q2 14.4M $39.4M +$58.1K $2.80 17
2019 Q1 14.4M $29.7M -$648K $2.06 20
2018 Q4 14.8M $25.3M +$10.1M $1.71 16
2018 Q3 8.85M $19.1M +$108K $2.16 14
2018 Q2 8.8M $20.6M +$1.06M $2.34 16
2018 Q1 8.37M $15.2M +$171K $1.81 8
2017 Q4 8.28M $14.9M +$14.9M $1.80 9